Lactameal250 mg+400 mg

Established Uses

Lactameal 250 mg+400 mg is an antacid used for the relief of heartburn, acid indigestion, sour stomach, and upset stomach caused by excess stomach acid. This is symptomatic relief only; Lactameal 250 mg+400 mg does not treat the underlying cause of these symptoms.

Additional / Adjunctive Uses

Lactameal 250 mg+400 mg is also commonly used, generally on a doctor's advice, to help relieve the discomfort of hyperacidity, gastritis, dyspepsia, and as a symptomatic adjunct alongside other treatment for peptic ulcer disease. In this adjunctive role, Lactameal 250 mg+400 mg eases acid-related discomfort but is not a treatment for the ulcer itself.

Lactameal 250 mg+400 mg is available in more than one strength and dosage form. Commonly marketed presentations include: chewable tablets containing Aluminium Hydroxide 250 mg and Magnesium Hydroxide 400 mg per tablet; and oral suspensions containing Aluminium Hydroxide (as aluminium oxide) 175 mg with Magnesium Hydroxide 225 mg per 5 mL, or Aluminium Hydroxide 200 mg with Magnesium Hydroxide 200 mg per 5 mL, depending on the brand. Always check the exact strength stated on the specific product label, since strengths vary by brand and formulation.

Lactameal 250 mg+400 mg is a combination antacid that is widely used for quick, short-term relief of heartburn, acid indigestion, and an upset or sour stomach. It works directly in the stomach to neutralize excess acid rather than being absorbed into the bloodstream to act elsewhere in the body. The two ingredients are combined because aluminium hydroxide tends to be constipating while magnesium hydroxide tends to loosen stools, so together they offer more balanced bowel effects than either ingredient used alone. Lactameal 250 mg+400 mg is available as chewable tablets and as an oral suspension, and is intended for occasional or short-term use rather than for treating the underlying disease causing the symptoms.

Lactameal 250 mg+400 mg acts mainly through local, non-systemic action within the gastrointestinal tract rather than through absorption into the body. Both components react chemically with hydrochloric acid in the stomach to neutralize it, raising intragastric pH and thereby relieving acid-related discomfort and reducing pepsin activity. Aluminium hydroxide has a relatively slow but sustained neutralizing action and may form a soothing coating over irritated mucosa, while magnesium hydroxide neutralizes acid more rapidly. Only small amounts of aluminium and magnesium are absorbed systemically under normal use in people with normal kidney function; unabsorbed drug is eliminated in the stool, while any absorbed aluminium and magnesium are eliminated mainly by the kidneys. Because elimination depends on renal function, people with impaired kidney function can accumulate aluminium and magnesium with prolonged use (see Precautions and Warnings).

• Shake the oral suspension well before each use to ensure an even dose.
• Chewable tablets should be chewed thoroughly before swallowing, not swallowed whole.
• Take Lactameal 250 mg+400 mg with a glass of water, typically 1 to 3 hours after meals and at bedtime, or as directed by a doctor or the product label.
• Separate Lactameal 250 mg+400 mg from other oral medicines by the interval noted for that specific medicine (see Drug Interactions), since taking them together can reduce absorption of the other drug.
• Do not use the maximum labeled dose for more than 2 weeks without medical advice, and stop use and see a doctor if symptoms persist or worsen.

• Tetracycline antibiotics (e.g., tetracycline, doxycycline): Aluminium and magnesium ions chelate with tetracyclines to form poorly absorbed complexes, reducing antibiotic levels. Separate dosing by at least 2 to 4 hours.
• Fluoroquinolone antibiotics (e.g., ciprofloxacin): chelation by aluminium and magnesium cations can reduce fluoroquinolone absorption substantially. Take the fluoroquinolone about 2 hours before, or 4 to 6 hours after, Lactameal 250 mg+400 mg.
• Oral iron supplements: raised gastric pH and complex formation reduce iron absorption. Separate dosing by at least 2 hours.
• Azole antifungals (e.g., ketoconazole, itraconazole): these drugs need an acidic stomach environment to dissolve and be absorbed; the antacid effect of Lactameal 250 mg+400 mg can reduce their absorption. Separate dosing by at least 2 hours.
• Levothyroxine (thyroid hormone): can be adsorbed or complexed by aluminium/magnesium, reducing absorption. Separate dosing by at least 2 hours, or as advised by a doctor.
• Digoxin: absorption and bioavailability may be altered. Separate dosing by at least 2 hours and monitor as advised by a doctor.
• Gabapentin: absorption can be reduced. Take gabapentin at least 2 hours after Lactameal 250 mg+400 mg.
• Bisphosphonates (e.g., alendronate): absorption is markedly reduced by concurrent antacid use; avoid taking together and separate by several hours as directed by a doctor or pharmacist.
• Because Lactameal 250 mg+400 mg can reduce the absorption of a number of other oral medicines through chelation or by raising gastric pH, always tell a doctor or pharmacist about all other medicines being taken so that appropriate spacing can be advised.

Common Side Effects

Constipation (more associated with the aluminium component), diarrhea or loose stools (more associated with the magnesium component), mild stomach cramps, and chalky taste. Effects on bowel habit are usually mild and dose-related.

Serious Side Effects — Seek Medical Attention

Seek medical attention if any of the following occur: signs of an allergic reaction (rash, itching, swelling of the face/lips/tongue, difficulty breathing); persistent or severe constipation or diarrhea; signs of electrolyte disturbance such as unusual tiredness, muscle weakness, irregular heartbeat, or confusion, particularly with prolonged or excessive use or in people with kidney disease (see Precautions and Warnings); or symptoms that persist beyond 2 weeks of use.

Pregnancy

Lactameal 250 mg+400 mg does not have a formal pregnancy risk category assigned. Controlled human data are limited, but antacids such as Lactameal 250 mg+400 mg are commonly used for heartburn in pregnancy when non-drug measures are insufficient. As a precaution, some experts recommend avoiding routine use in the first trimester, and pregnant women should use Lactameal 250 mg+400 mg only after discussing it with a doctor, who can weigh the expected benefit against any potential risk.

Breastfeeding

Magnesium hydroxide is known to pass into breast milk in small amounts; data on aluminium hydroxide in breast milk are limited. Lactameal 250 mg+400 mg is generally considered acceptable to use while breastfeeding, but a doctor should be consulted before use, and the nursing infant should be watched for any unusual stooling pattern.

• Kidney disease / renal impairment: aluminium and magnesium are cleared mainly by the kidneys, so people with reduced kidney function, and those on dialysis, can accumulate these minerals with prolonged or high-dose use, raising the risk of toxicity (including, rarely, aluminium-related bone or neurological effects). A doctor should be consulted before use in anyone with known kidney disease, and prolonged use should be avoided in this group unless a doctor advises otherwise.
• Magnesium-restricted diet: ask a doctor before use, since Lactameal 250 mg+400 mg adds to magnesium intake.
• Duration and dose limits: do not use the maximum labeled dose for more than 2 weeks, or exceed the maximum daily dose on the label, unless directed by a doctor, as excessive or prolonged use raises the risk of electrolyte disturbance and bowel changes.
• Other medicines: Lactameal 250 mg+400 mg can reduce the absorption of a number of other oral drugs; see Drug Interactions for the full list and recommended spacing.
• Persistent or worsening symptoms: stop use and see a doctor if heartburn or stomach symptoms persist beyond 2 weeks, or if they are accompanied by unexplained weight loss, difficulty swallowing, vomiting blood, or black/tarry stools, as these may indicate a condition needing separate evaluation.

The most likely effects of taking more than the recommended amount of Lactameal 250 mg+400 mg are gastrointestinal — diarrhea or, alternately, constipation, abdominal bloating, and cramping. With substantial or prolonged excessive intake, electrolyte disturbances can occur, including elevated magnesium levels (more likely in people with reduced kidney function), which may cause symptoms such as low blood pressure, muscle weakness, drowsiness, or an irregular heartbeat, and, rarely, aluminium accumulation with long-term excessive use. Do not induce vomiting unless specifically directed to do so by a doctor or poison control center. If an overdose of Lactameal 250 mg+400 mg is suspected, contact a doctor, the nearest hospital emergency department, or a poison control center promptly.

Store Lactameal 250 mg+400 mg according to the instructions on the specific product's label, as recommended conditions can vary by brand and formulation (tablet versus suspension). Unless the label states otherwise, store in a cool, dry place below 30°C, protected from direct light and moisture, and keep out of the reach of children. Do not use beyond the expiry date printed on the pack.

• Children: not intended for self-directed use under 12 years of age; a physician should be consulted (see Pediatric Use).
• Elderly: no specific dose adjustment is established for otherwise healthy older adults, but elderly patients are more likely to have reduced kidney function, so the renal-impairment caution below applies particularly to this group; use should be guided by a doctor for regular or prolonged use.
• Renal impairment: see Precautions and Warnings for details on the risk of aluminium and magnesium accumulation with prolonged or high-dose use in people with kidney disease.
• Hepatic impairment: Lactameal 250 mg+400 mg is not metabolized by the liver in a way that requires a specific dose adjustment in liver disease; nonetheless, use should follow a doctor's advice in anyone with significant hepatic impairment.
• Pregnancy and breastfeeding: see Pregnancy and Lactation.
• Magnesium-restricted diets or hypermagnesemia risk: a doctor should be consulted before use.

Lactameal 250 mg+400 mg is generally intended for short-term or as-needed relief of occasional heartburn, acid indigestion, and upset stomach. Self-directed use at the maximum labeled dose should not continue for more than 2 weeks unless a doctor has advised otherwise. When Lactameal 250 mg+400 mg is used as an adjunct alongside treatment for gastritis or peptic ulcer disease, the duration is set by the treating doctor based on the underlying condition. If symptoms persist, recur frequently, or worsen despite use, a doctor should be seen to check for an underlying condition that may need separate treatment.

Aluminium hydroxide reacts with hydrochloric acid in the stomach to form aluminium chloride and water, while magnesium hydroxide reacts with hydrochloric acid to form magnesium chloride and water; both reactions neutralize gastric acid and raise intragastric pH, which in turn reduces the activity of pepsin. Aluminium hydroxide has a slower, more sustained neutralizing action and tends to have a constipating effect on the bowel, whereas magnesium hydroxide neutralizes acid more quickly and tends to have a laxative effect; combining the two in Lactameal 250 mg+400 mg is intended to balance these opposing bowel effects while providing effective acid neutralization.

Lactameal 250 mg+400 mg is not recommended for self-directed (non-prescribed) use in children under 12 years of age; a physician should be consulted first to confirm the diagnosis and appropriateness of use. Under direct medical supervision, reduced doses have been described for older children (for example, some clinical guidance describes half a chewable tablet given up to three times daily in children over 5 years for gastritis-related stomach pain), but such use is uncommon and should only be started and monitored by a doctor. Use of Lactameal 250 mg+400 mg in infants and children under 5 years has not been established and is not recommended without specific medical guidance.